ResearcherThe University of OsakaActive in the last 2 years
Hirofumi Yamamoto
Matched on ORCID iD 0000-0001-6959-9574; OpenAlex author ID A5069920480. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 11
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 4
- miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer. Co-author DOI 10.3390/ijms27083686↗
- Lymphocyte Antigen 6 Family Member D (LY6D) Affects Stem Cell Phenotype and Progression of Pancreatic Adenocarcinoma. Last author DOI 10.21873/anticanres.17300↗
- KRT13 is upregulated in pancreatic cancer stem-like cells and associated with radioresistance. Last author DOI 10.1093/jrr/rrac091↗
- The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells. Co-author DOI 10.1093/jrr/rrx033↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuhki Yokoyama · 4 shared papers, 2017–2026 · strength 0.69
- Paper miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer. DOI 10.3390/ijms27083686↗
- Paper Lymphocyte Antigen 6 Family Member D (LY6D) Affects Stem Cell Phenotype and Progression of Pancreatic Adenocarcinoma. DOI 10.21873/anticanres.17300↗
- Paper KRT13 is upregulated in pancreatic cancer stem-like cells and associated with radioresistance. DOI 10.1093/jrr/rrac091↗
- Masahiko Koizumi · 2 shared papers, 2017–2023 · strength 0.25
- Masaki Mori · 1 shared paper, 2026 · strength 0.25
- Hiroyuki Yamamoto · 1 shared paper, 2026 · strength 0.25
- Shumpei Okimura · 1 shared paper, 2024 · strength 0.18
- Masaki Mori · 1 shared paper, 2024 · strength 0.18
- Yuichiro Doki · 1 shared paper, 2024 · strength 0.18
- Hidetoshi Eguchi · 1 shared paper, 2024 · strength 0.18
- Hidenori Takahashi · 1 shared paper, 2024 · strength 0.18
- Wataru Takenaka · 1 shared paper, 2023 · strength 0.18
- Kento Tsubouchi · 1 shared paper, 2017 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.